Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:04 PM
Ignite Modification Date:
2025-12-25 @ 4:37 PM
NCT ID:
NCT02810457
Group ID:
EG001
Title:
Avastin / Paclitaxel / Carboplatin
Description:
Drug: Avastin:
15 mg/kg IV infusion on Day 1 of each 21-day cycle.
Drug: Paclitaxel:
200 mg/m2 IV infusion on Day 1 of each 21-day cycle for at least 4 and no more than 6 cycles.
Drug: Carboplatin:
AUC = 6.0 IV infusion on Day 1 of each 21-day cycle for at least 4 and no more than 6 cycles.
Avastin (bevacizumab)
Paclitaxel
Carboplatin
Deaths Number Affected:
177
Deaths Number At Risk:
None
Serious Number Affected:
95
Serious Number At Risk:
366
Other Number Affected:
348
Other Number At Risk:
366
Study:
NCT02810457
Results Section:
NCT02810457
Adverse Events Module:
NCT02810457